The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBPET.L Regulatory News (BPET)

  • There is currently no data for BPET

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

15 Dec 2006 11:04

F&C Private Equity Trust PLC15 December 2006 F&C Private Equity Trust PLC ("F&CPET") Portfolio Review for the two months to 30 September 2006 • Interim Dividends of 1.0p per A share and 2.1p per B share • NAV increases of 2.9% per A share and 2.0% per B share • 3 new fund commitments • High levels of investment activity Net Asset Values and Dividends The Company has changed its year-end and this is the first review using calendaryear quarter end dates. The review covers the two-month period since the 31 Julyvaluation. The C pool converted completely into the B pool on 25 September andthe small residual portfolio of smaller company stocks (£0.6m) is now helddirectly in the B pool. The A pool had net assets of £25.2m at 30 September.This has now reduced by £10.4m following the payment of the special dividend of15.5p per A share on 20 October. The NAV per A share at 30 September was 37.52p,an increase since 31 July of 2.9%. The B pool had net assets of £122.6m at 30September. The NAV per B share was 169.62p, an increase since 31 July of 2.0%. An interim dividend in respect of the period to 31 December 2006 of 1.0p per Ashare and 2.1p per B share will be paid on 19 January 2007 to those shareholderson the register at 29 December 2006. New Commitments During the two-month period the Company has made three new fund commitments.These cover new geographic areas for F&C PET. €5m has been committed to GildeBuyout Fund III. This fund covers the Benelux and neighbouring countries. Gildeis one of the better-known Dutch-based mid-market private equity groups. F&C PEThas also made its first commitment to Italy through the purchase of a secondaryposition in Alto Capital I for €3.24m. Subsequent to the quarter-end anadditional commitment of €3m was made to Alto's new fund. After having reviewednumerous Asian funds over the years, we have made our first commitment to apurely Asian fund, through a $5m participation in AIF Capital Asia III. This isa particularly strong and experienced team who cover the principal markets ofGreater China and India. Since the quarter-end we have acquired another secondary investment in the formof Argan Capital - the former Bank of America European private equity team andportfolio. €4.9m was invested in this fund giving immediate exposure to amaturing portfolio. More recently we have invested $4.2m in 3si, the US-basedcash security and protection company. This deal was led by Stirling SquareCapital Partners. Additionally, F&C PET invested £2m for 15.5% of EuropeanBoating Holidays (RJD lead) and an additional £0.75m has been invested inEquidebt, the debt collection company, to help with its growth plans. Veryrecently £5m has been committed to Alchemy Special Opportunities Fund. There area number of other commitments and co-investments under consideration and some ofthese will be implemented before the end of 2006. The total outstandingcommitments of the B pool, including those made after the end of September, are£138m. At 30 September the B pool had cash and cash equivalents of £30.2m.Since the quarter-end drawdowns and new investments have reduced liquidity toapproximately £20m. Drawdowns Total drawdowns and new investments in the two month period amounted to £6.94m.The more notable individual investments included £906,087 by Candover 2005 intoprivate mail company DX/SMS - £460,000 by Primary Capital III into Tobar, amultichannel vendor of toys, gifts and gadgets; £310,282 by Blue Point CapitalPartners II into DriEaz, a company specializing in drying products; a combined£723,455 by Inflexion (through fund II and HFP) into Parasol, a leadingemployment agency in the North West of England; and £382,108 by Chequers intoHBI, the vehicle for taking private catering company Elior. Realisations Realisations from funds and direct investments totalled £2.5m over the twomonths. Chequers Capital distributed £454,429. This was from the partial sale ofTractel (building hoists) where Chequers have so far achieved a 31% IRR, andrefinancing of Fregate (warehouse systems) where the IRR is 38%. Academy MusicGroup completed its refinancing returning £704,126. International MezzanineInvestment redeemed another tranche of loan stock and F&C PET's share of thiswas £469,641. Valuation Changes The total valuation uplift for the portfolio is £3.6m. The largest individualcontributor to this was Gondola Holdings which, with its imminent realisation,contributed £1.28m. Other large gains were Hicks Muse Fund IV (£577,329) wherethe Latin American media investment Davivo has come good; Candover 1997 Fund(£521,745) with the sale of Vestolit now announced; and Inflexion (£264,557) andHFP (£477,981) both beneficiaries from the sale of ACIS. The impact of foreignexchange movements was minimal with an adverse movement of £0.2m. Outlook The dealflow of new fund and direct investment opportunities is strong. We havebeen encouraged by the number and quality of secondary opportunities. These haveallowed us to deploy a significant amount of the Company's liquidity intomaturing portfolios where there are good prospects of positive returns over themedium term. The co-investment portfolio is developing well at the underlyingcompany level and we would expect that 2007 will see some worthwhilerealisations. We have experienced a very busy period for new investments andthis pace of activity is likely to moderate somewhat in the New Year. For more information Hamish Mair, F&C Asset Management plc Mike Woodward, F&C Asset Management plc Tel. 0131 718 1000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Jun 20223:22 pmRNSChange of Name
17th Jun 20224:07 pmRNSTransaction in Own Shares
15th Jun 20225:01 pmRNSTransaction in Own Shares
27th May 20229:08 amRNSResult of Annual Gen Meeting & Directorate Change
26th May 202212:02 pmRNS1st Quarter Results
27th Apr 202210:07 amRNSDirector/PDMR Shareholding
27th Apr 202210:06 amRNSDirector/PDMR Shareholding
27th Apr 202210:04 amRNSDirector/PDMR Shareholding
26th Apr 20223:24 pmRNSDirector/PDMR Shareholding
26th Apr 20223:23 pmRNSDirector/PDMR Shareholding
25th Apr 20229:24 amRNSDirector/PDMR Shareholding
8th Apr 20227:00 amRNSAnnual Financial Report
1st Apr 202210:17 amRNSHolding(s) in Company
1st Apr 202210:09 amRNSHolding(s) in Company
30th Mar 20222:56 pmRNSDirector/PDMR Shareholding
30th Mar 20222:54 pmRNSDirector/PDMR Shareholding
25th Mar 20227:00 amRNSAnnual Financial Report
17th Feb 20227:00 amRNSDirectorate Change
14th Jan 20227:00 amRNSUpdate on Secondary Placing
13th Jan 20227:00 amRNSProposed Secondary Placing
4th Jan 20227:00 amRNSInvestor Presentation
26th Nov 20217:00 amRNS3rd Quarter Results
22nd Nov 202110:47 amRNSHolding(s) in Company
15th Oct 20219:55 amRNSHolding(s) in Company
15th Oct 20217:00 amRNSKepler Trust Intelligence: New Research
27th Aug 20217:00 amRNSInterim results and Quarterly Dividend
25th Jun 20213:14 pmRNSHolding(s) in Company
27th May 20212:15 pmRNSAGM Statement
27th May 202111:51 amRNSQuarterly NAV and Dividend Announcement
29th Apr 20211:01 pmRNSHolding(s) in Company
19th Apr 20217:00 amRNSAnnual Financial Report
26th Mar 20217:00 amRNSFinal Results
24th Mar 20217:00 amRNSInvestment Update
8th Feb 20213:00 pmRNSHolding(s) in Company
9th Dec 20209:22 amRNSHolding(s) in Company
27th Nov 202010:52 amRNSHolding(s) in Company
25th Nov 20209:18 amRNSKepler Trust Intelligence: New Research
20th Nov 20207:00 amRNSQuarterly results and dividend announcement
15th Oct 20204:09 pmRNSNon-Executive Director Declaration
18th Sep 20202:09 pmRNSDirector/PDMR Shareholding
16th Sep 20202:24 pmRNSDirector/PDMR Shareholding
15th Sep 20203:42 pmRNSHolding(s) in Company
1st Sep 202012:24 pmRNSDirector/PDMR Shareholding
21st Aug 20207:00 amRNSInterim Results
20th Jul 20207:00 amRNSNon-Executive Director Declaration
17th Jul 20207:00 amRNSAppointment of Corporate Broker
9th Jun 20209:57 amRNSHolding(s) in Company
4th Jun 20207:00 amRNSDirectorate Change
22nd May 20204:11 pmRNSHolding(s) in Company
21st May 20207:00 amRNSFirst Quarter Results and Dividend Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.